The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, D. W.
Right arrow Articles by Hoffman, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, D. W.
Right arrow Articles by Hoffman, M. D.

The Journal of Immunology, Vol 132, Issue 6 2807-2812, Copyright © 1984 by American Association of Immunologists


ARTICLES

Identification of macrophage receptors for angiotensin: a potential role in antigen uptake for T lymphocyte responses?

DW Thomas and MD Hoffman

To determine if macrophages express receptors for peptide antigens, guinea pig peritoneal exudate cells (PEC) were examined for their uptake of the octapeptide angiotensin II (AII). PEC were incubated with [3H]AII, with or without nonradioactive AII as a cold inhibitor, for varying lengths of time before harvesting to determine the cell- associated [3H]AII counts per minute. The PEC-associated [3H]AII increased from 90 to 120 min of incubation, then plateaued on additional incubation to 3.5 hr. Inclusion of nonradiolabeled AII into the culture decreased the cell-associated [3H]AII by 80 to 90% at all time points. The uptake of [3H]AII was temperature-sensitive, with maximum cell-associated [3H]-AII occurring at 37 degrees C and reduced uptake occurring at 4 degrees C. The association of [3H]AII with PEC was specific and saturable, and the inhibitory dose for reducing the cell-associated [3H]AII by 50% with nonradiolabeled AII was around 6 X 10(-6) M. Various AII analogs were also employed as inhibitors to determine the fine specificity of [3H]AII binding, and only those analogs with nonaromatic amino acid substitutions for the carboxyl terminal Phe8 showed reduced inhibitory activity, indicating that Phe8 is important for binding. Scatchard analysis of binding indicated that two classes of receptors interacted with AII: a low number of receptors with Ka approximately equal to 3.5 X 10(8) M-1, and a large number of relatively low affinity of binding showing a Ka approximately equal to 5 X 10(5) M-1. The cellular binding activity was associated with isolated PEC plasma membranes, and after density gradient fractionation of solubilized membranes, AII binding activity was primarily associated with molecules of m.w. of around 50,000. PEC were separated into macrophages and lymphocytes by adherence, and all of the [3H]AII binding activity was associated with the macrophage-enriched cells. These results show that macrophages express specific receptors for AII and related peptides that are responsible for most of the uptake of AII by macrophages. We discuss the relevance of this receptor for the immunologically important uptake of AII by macrophages, and a potential physiologic role in angiotensin-converting enzyme production.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
M. Paul, A. Poyan Mehr, and R. Kreutz
Physiology of local Renin-Angiotensin systems.
Physiol Rev, July 1, 2006; 86(3): 747 - 803.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Yanagitani, H. Rakugi, A. Okamura, K. Moriguchi, S. Takiuchi, M. Ohishi, K. Suzuki, J. Higaki, and T. Ogihara
Angiotensin II Type 1 Receptor–Mediated Peroxide Production in Human Macrophages
Hypertension, January 1, 1999; 33(1): 335 - 339.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. D. Potter, C. G. Sobey, P. K. Tompkins, J. D. Rossen, and D. D. Heistad
Evidence That Macrophages in Atherosclerotic Lesions Contain Angiotensin II
Circulation, August 25, 1998; 98(8): 800 - 807.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Porreca, C. Di Febbo, G. Mincione, M. Reale, G. Baccante, M. D. Guglielmi, F. Cuccurullo, and G. Colletta
Increased Transforming Growth Factor-ß Production and Gene Expression by Peripheral Blood Monocytes of Hypertensive Patients
Hypertension, July 1, 1997; 30(1): 134 - 139.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Raiden, M. Giordano, G. Andonegui, A. S. Trevani, D. H. López, V. Nahmod, and J. R. Geffner
Losartan, a Selective Inhibitor of Subtype AT1 Receptors for Angiotensin II, Inhibits the Binding of N-Formylmethionyl-leucyl-phenylalanine to Neutrophil Receptors
J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 624 - 628.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Kitazono, R. C. Padgett, M. L. Armstrong, P. K. Tompkins, and D. D. Heistad
Evidence That Angiotensin II Is Present in Human Monocytes
Circulation, February 15, 1995; 91(4): 1129 - 1134.
[Abstract] [Full Text]


Home page
ScienceHome page
S Buus, A Sette, S. Colon, C Miles, and H. Grey
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides
Science, March 13, 1987; 235(4794): 1353 - 1358.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.